Search Results - "Remm, Friederike"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
  2. 2

    Sitagliptin Accelerates Endothelial Regeneration after Vascular Injury Independent from GLP1 Receptor Signaling by Sopper, Sieghart, Drucker, Daniel J., Lener, Daniela, Kränkel, Nicolle, Remm, Friederike, Brenner, Christoph

    Published in Stem cells international (01-01-2018)
    “…Introduction. DPP4 inhibitors (gliptins) are commonly used antidiabetic drugs for the treatment of type 2 diabetes. Gliptins also act in a glucose-independent…”
    Get full text
    Journal Article
  3. 3

    Gliptins and their target dipeptidyl peptidase 4: implications for the treatment of vascular disease by Remm, Friederike, Franz, Wolfgang-Michael, Brenner, Christoph

    “…Gliptins are accepted as a standard therapy for diabetes mellitus today. By inhibition of the enzyme dipeptidyl peptidase 4 (DPP4), gliptins prolong the…”
    Get full text
    Journal Article
  4. 4

    Abstract 13248: DPP-4 Inhibition Reduces Atherosclerosis by Priming Monocytes into Alternative M2 Macrophages by Brenner, Christoph, Franz, Wolfgang M, Kuehlenthal, Sarah, Kuschnerus, Kira, Remm, Friederike, Theiss, Hans D, Landmesser, Ulf, Krankel, Nicolle

    Published in Circulation (New York, N.Y.) (25-11-2014)
    “…Abstract only Introduction: Major parts of the population in the western world are suffering from atherosclerotic diseases like coronary and peripheral artery…”
    Get full text
    Journal Article